Showing results (71-80 of 108) with videos related to
Sort By:
Pageof 11
Journal of Clinical Microbiology|July 10, 2004
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida sppM A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|November 23, 2007
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillanceM A Pfaller, L Boyken, R J Hollis, et al.Journal of Clinical Microbiology|July 3, 1998
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant GroupM A Pfaller, R N Jones, G V Doern, et al.Journal of Clinical Microbiology|October 4, 2000
Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episodeK Vargas, S A Messer, M Pfaller, et al.Journal of Clinical Microbiology|July 10, 2004
Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolatesM A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|August 28, 2009
In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution methodM A Pfaller, L Boyken, R J Hollis, et al.Journal of Clinical Microbiology|August 28, 2009
In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methodsD J Diekema, S A Messer, L B Boyken, et al.Journal of Clinical Microbiology|March 8, 2003
Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from bloodM J Maxwell, S A Messer, R J Hollis, et al.Antimicrobial Agents and Chemotherapy|October 28, 2005
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasisM A Pfaller, D J Diekema, L Boyken, et al.Journal of Clinical Microbiology|February 13, 1999
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organismsA Espinel-Ingroff, M Pfaller, S A Messer, et al.Pageof 11